// App-Quantinova.ai

: Immunotherapy-induced Diabetes Mellitus is not uncommon

Researchers

Presenter

  • Janessa Bell

Principal Investigators

  • Mahamud Bashir

  • Hassan Rehmani

  • Gideon Mlawa

Medical Centers

  • Queen’s Hospital, Acute Medicine, London, United Kingdom

  • American University of the Caribbean School of Medicine, Sint Maarten (Dutch Part)

  • Queen`s Hospital, Diabetes and Endocrinology/Acute Medicine, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Addison's disease

  • Diabetes

  • Type 1 diabetes mellitus

  • Juvenile dermatomyositis

Biomarkers

  • Cortisol

Drug/Treatment

  • Pembrolizumab

  • Pemetrexed

  • NovoRapid

  • Cisplatin

  • Insulin detemir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved